Kim Kyung-Eun, Park Mi-Suk, Chung Sohae, An Chansik, Axel Leon, Ergashovna Rakhmonova Gulbahor
Department of Radiology and Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea.
Center for Biomedical Imaging, Department of Radiology, New York University Langone Medical Center, New York, USA.
Clin Mol Hepatol. 2016 Mar;22(1):140-5. doi: 10.3350/cmh.2016.22.1.140. Epub 2016 Mar 28.
BACKGROUND/AIMS: To assess the usefulness of magnetization-tagged magnetic resonance imaging (MRI) in quantifying cardiac-induced liver motion and deformation in order to predict liver fibrosis.
This retrospective study included 85 patients who underwent liver MRI including magnetization-tagged sequences from April 2010 to August 2010. Tagged images were acquired in three coronal and three sagittal planes encompassing both the liver and heart. A Gabor filter bank was used to measure the maximum value of displacement (MaxDisp) and the maximum and minimum values of principal strains (MaxP1 and MinP2, respectively). Patients were divided into three groups (no fibrosis, mild-to-moderate fibrosis, and significant fibrosis) based on their aspartate-aminotransferase-to-platelet ratio index (APRI) score. Group comparisons were made using ANOVA tests.
The patients were divided into three groups according to APRI scores: no fibrosis (≤ 0.5; n=41), moderate fibrosis (0.5-1.5; n=23), and significant fibrosis (>1.5; n=21). The values of MaxDisp were 2.9 ± 0.9 (mean ± SD), 2.3 ± 0.7, and 2.1 ± 0.6 in the no fibrosis, moderate fibrosis, and significant fibrosis groups, respectively (P<0.001); the corresponding values of MaxP1 were 0.05 ± 0.2, 0.04 ± 0.02, and 0.03 ± 0.01, respectively (P=0.002), while those of MinP2 were -0.07 ± 0.02, -0.05 ± 0.02, and -0.04 ± 0.01, respectively (P<0.001).
Tagge d MRI to quantify cardiac-induced liver motion can be easily incorporated in routine liver MRI and may represent a helpful complementary tool in the diagnosis of early liver fibrosis.
背景/目的:评估磁化标记磁共振成像(MRI)在量化心脏引起的肝脏运动和变形以预测肝纤维化方面的实用性。
这项回顾性研究纳入了2010年4月至2010年8月期间接受肝脏MRI检查(包括磁化标记序列)的85例患者。在包含肝脏和心脏的三个冠状面和三个矢状面上采集标记图像。使用Gabor滤波器组测量位移最大值(MaxDisp)以及主应变的最大值和最小值(分别为MaxP1和MinP2)。根据患者的天冬氨酸转氨酶与血小板比值指数(APRI)评分将其分为三组(无纤维化、轻度至中度纤维化和重度纤维化)。使用方差分析进行组间比较。
根据APRI评分,患者被分为三组:无纤维化(≤0.5;n = 41)、中度纤维化(0.5 - 1.5;n = 23)和重度纤维化(>1.5;n = 21)。无纤维化组、中度纤维化组和重度纤维化组的MaxDisp值分别为2.9±0.9(平均值±标准差)、2.3±0.7和2.1±0.6(P<0.001);MaxP1的相应值分别为0.05±0.2、0.04±0.02和0.03±0.01(P = 0.002),而MinP2的值分别为 - 0.07±0.02、 - 0.05±0.02和 - 0.04±0.01(P<0.001)。
用于量化心脏引起的肝脏运动的标记MRI可以很容易地纳入常规肝脏MRI检查中,并且可能是早期肝纤维化诊断中一种有用的辅助工具。